Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy

Jake B Guinto1, Gillian P Ritson, J Paul Taylor

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 422 Curie Blvd., 605B Stellar-Chance Building, Philadelphia, PA, 19104-6140, USA.

Acta Neuropathologica
|April 26, 2007
PubMed

Insights

Frontotemporal dementia with inclusion body myopathy and Paget's disease of bone (IBMPFD), caused by VCP gene mutations, presents unique brain pathology. This review explores IBMPFD's distinct ubiquitin inclusions and VCP protein's role in cellular functions.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Frontotemporal dementia with inclusion body myopathy and Paget's disease of bone (IBMPFD) is a rare autosomal dominant disorder.
  • Mutations in the valosin-containing protein (VCP) gene are the known cause of IBMPFD.
  • The disease affects the central nervous system (CNS), muscles, and bones.

Purpose of the Study:

  • To review the current literature on IBMPFD.
  • To focus on the pathology of the disease, particularly CNS involvement.
  • To explore the biology of the VCP gene and its relation to IBMPFD.

Main Methods:

  • Literature review of existing studies on IBMPFD.
  • Analysis of CNS pathology, including ubiquitin and TAR DNA binding protein staining.
  • Examination of VCP protein's cellular functions and involvement in IBMPFD.

Main Results:

  • IBMPFD exhibits a unique pattern of ubiquitin pathology in the CNS.
  • These ubiquitin inclusions also stain positive for TAR DNA binding protein.
  • This finding links IBMPFD pathology to other forms of frontotemporal lobar degeneration (FTLD).

Conclusions:

  • VCP mutations lead to a distinct neuropathology in IBMPFD.
  • Understanding VCP's role in cellular processes is crucial for elucidating disease mechanisms.
  • Further research is needed to fully understand how VCP mutations cause multi-system disease.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...